Skip to content
← Full study record

NCT00118352 · MORE INFO

Limitations, agreements, and source contact

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · Source last updated 2017-05-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
bsandmai@fhcrc.org
organization
Fred Hutchinson Cancer Research Center
phone
(206) 667-4961
title
Dr. Brenda M. Sandmaier
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
bsandmai@fhcrc.org
organization
Fred Hutchinson Cancer Research Center
phone
(206) 667-4961
title
Dr. Brenda M. Sandmaier

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice